Fig. 4.
Fig. 4. Protection from EAE induction by B cells transduced with the MPL-PURO vector virus. / Each symbol represents an individual mouse. Mice were treated with transduced B cells 7 to 10 days before induction of EAE. EAE was scored as described in “Material and methods.” (A) Progression of EAE in 6 mice that were treated with MPL-PURO–infected spleen B cells, which express the PLP encephalitogenic determinant. (B) Progression of EAE in 3 mice treated with B cells transduced with MML-PURO, which express the encephalitogenic determinant of MBP. (C) Progression of EAE in 5 untreated syngeneic-sex and age-matched control mice. Group A is significantly different from groups B and C (P < .05).

Protection from EAE induction by B cells transduced with the MPL-PURO vector virus.

Each symbol represents an individual mouse. Mice were treated with transduced B cells 7 to 10 days before induction of EAE. EAE was scored as described in “Material and methods.” (A) Progression of EAE in 6 mice that were treated with MPL-PURO–infected spleen B cells, which express the PLP encephalitogenic determinant. (B) Progression of EAE in 3 mice treated with B cells transduced with MML-PURO, which express the encephalitogenic determinant of MBP. (C) Progression of EAE in 5 untreated syngeneic-sex and age-matched control mice. Group A is significantly different from groups B and C (P < .05).

Close Modal

or Create an Account

Close Modal
Close Modal